Report / Trial registry metadata
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
A registered study record. Recorded registry status: RECRUITING. A registry entry is not a treatment recommendation or proof that a study succeeded.
Limits
No clinical review has been performed. This record is not a treatment recommendation, eligibility confirmation or current availability guarantee.
- Kind
- Trial registry metadata
- Status
- RECRUITING